ISRCTN24045888已完成未知
of-1 trials of stimulants versus placebo and each other for Attention Deficit Hyperactivity Disorder in children
The University of Queensland (Australia)0 个研究点目标入组 86 人开始时间: 2007年8月16日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 86
研究概览
简要总结
2006 results in: https://www.ncbi.nlm.nih.gov/pubmed/16740846 (added 21/05/2019)
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Any school age patient with a clinical diagnosis of ADHD of at least a month's duration, in the opinion of the attending medical practitioner, who is stabilised on treatment with Ritalin
- •2. Patient, parent and doctor would like to use the n-of-1 trial methodology to see if the patient is a responder to methylphenidate or dexamphetamine
排除标准
- •1. Advanced arteriosclerosis
- •2. Symptomatic cardiovascular disease
- •3. Moderate to severe hypertension
- •4. Hyperthyroidism
- •5. Phaeochromocytoma
- •6. Glaucoma
- •7. Agitated states
- •8. Anxiety
- •9. Motor tics
- •10. Tourette syndrome
- •11. Monoamine Oxidase Inhibitors (MAOIs) (+/- 14 days)
- •12. Idiosyncratic reaction to sympathomimetic amines
- •13. History of drug abuse
研究者
相似试验
招募中
不适用
of-1 trials to evaluate the effect of stimulant vs placebo in pediatric traumatic brain injuryTraumatic brain injury in childrenNeurological - Other neurological disordersInjuries and Accidents - Other injuries and accidentsACTRN12609000873224The Univesity of Queensland42
已完成
1 期
Randomised, Double-blinded, Placebo-controlled Clinical Trial of Pandemic Influenza Inactive Vaccine on Healthy SubjectsISRCTN53344556Sinovac Biotech Co. Ltd (China)120
已完成
2 期
A phase II, double-blind, randomised, placebo-controlled study to assess the safety, reactogenicity and immunogenicity of three doses of GlaxoSmithKline (GSK) Biologicals? oral live attenuated human rotavirus (HRV) vaccine (RIX4414 at 106.5 CCID50) administered to human immunodeficiency virus (HIV) infected infants at 6, 10 and 14 weeks of age in South AfricaVaccine/immunisationInfections and InfestationsVaccinationISRCTN11877362World Health Organization (WHO)/Department of Immunisation, Vaccines and Biologicals (IVB) (Switzerland)100
已完成
不适用
A Multicentre Randomised and Comparative Trial to Assess the Tolerance, Efficacy and Pharmacokinetics of Escalating Doses of Casodex Versus Castration in the Treatment of Advanced Carcinoma of the ProstateProstateProstate cancerCancerISRCTN16559899AstraZeneca Clinical Research Group (UK)248
已完成
2 期
A Dose Finding Study of Preladenant (SCH 420814) for the Treatment of Parkinson's Disease (PD) in Japanese Patients (P06402)Parkinson's DiseaseNCT01294800Merck Sharp & Dohme LLC450